Rama Petrochem (500358)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹8.6 |
| Market Cap | ₹9.01 Cr |
| P/E Ratio | 0 |
| ROCE | 0% |
| ROE | 12.65% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹12.05 — ₹16.12 |
| Sector | Finance |
Strengths
- Reported ROE of 12.65% is positive, though contradicted by the latest quarterly loss.
- Market cap of ₹9 Cr is tiny, so even a small absolute improvement could have a proportionally large impact.
- As an NBFC, if the underlying licence has any franchise value, it is not reflected in the current market cap.
- The low price may already reflect much of the negative news, reducing further downside if assets exist.
Concerns
- Latest quarter shows zero sales and a net loss of ₹2 Cr, indicating ongoing cash burn.
- Piotroski F-Score of 3/9 suggests weak financial health and poor operating efficiency.
- Current price of ₹8.60 is below the 52-week range of ₹12.05 to ₹16.12, signalling persistent selling pressure.
- Critical data like book value, debt-to-equity, promoter holding, and detailed quarter numbers are unavailable, making valuation impossible.
AI Analysis
Let me be blunt: this is not a business I can value, and in my world, what you cannot value you should not own. Rama Petrochem shows a market cap of just ₹9 Cr, a price of ₹8.60, and yet the latest quarter has sales of ₹0 Cr and a net loss of ₹2 Cr. That is a cash burner, not a compounding machine. The P/E of 0.00 is meaningless because earnings are negative or absent. The ROE of 12.65% looks entirely inconsistent with the quarterly loss; perhaps it is trailing, but I do not buy on one ratio when the most recent facts are so poor. The Piotroski F-Score of 3/9 out of a possible 9 tells me the financial health is weak. The price is sitting below the 52-week range of ₹12.05 to ₹16.12, which means the market is rejecting this stock. There is no dividend, no sales growth, no profit growth, no promoter holding data, no book value, and no debt information. For an NBFC, the absence of asset quality and leverage data is disqualifying. Benjamin Graham always asked for a margin of safety; here I cannot even find the intrinsic value, let alone a margin. A ₹9 Cr market cap might tempt someone into hoping for a turnaround, but hope is not an investment strategy. The only rational move is to put this in the 'too hard' pile and wait for evidence of real revenue, positive earnings, and honest disclosure. I would rather pass on ten unknowns than lose my capital on one.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer